These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease. Shildkrot Y; Wilson MW Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367 [TBL] [Abstract][Full Text] [Related]
4. Metastatic uveal melanoma: diagnosis and treatment. A literature review. De Croock L; Verbraeken H Bull Soc Belge Ophtalmol; 2002; (286):59-63. PubMed ID: 12564318 [TBL] [Abstract][Full Text] [Related]
5. Locoregional management of hepatic metastasis from primary uveal melanoma. Sato T Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705 [TBL] [Abstract][Full Text] [Related]
6. Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye. Bourla DH; Young TA Semin Ophthalmol; 2007; 22(3):175-7. PubMed ID: 17763240 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of treatments for metastatic uveal melanoma. Augsburger JJ; Corrêa ZM; Shaikh AH Am J Ophthalmol; 2009 Jul; 148(1):119-27. PubMed ID: 19375060 [TBL] [Abstract][Full Text] [Related]
8. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation. Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163 [No Abstract] [Full Text] [Related]
9. [Risk factors of extraocular spread after local treatment of uveal melanoma]. Neroev VV; Saakian SV; Amirian AG; Val'skiĭ VV Vestn Oftalmol; 2011; 127(2):21-5. PubMed ID: 21721267 [TBL] [Abstract][Full Text] [Related]
11. [What else can we do for uveal melanoma]. Li B; Xu XL Zhonghua Yan Ke Za Zhi; 2009 Apr; 45(4):289-92. PubMed ID: 19575957 [TBL] [Abstract][Full Text] [Related]
12. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679 [TBL] [Abstract][Full Text] [Related]
13. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study. Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415 [TBL] [Abstract][Full Text] [Related]
15. Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival. Augsburger JJ; Corrêa ZM; Trichopoulos N Am J Ophthalmol; 2011 Jul; 152(1):5-9.e1. PubMed ID: 21601175 [TBL] [Abstract][Full Text] [Related]
16. Screening for uveal melanoma metastasis. Literature review. Missotten GS; Keunen JE Bull Soc Belge Ophtalmol; 2004; (294):13-22. PubMed ID: 15682915 [TBL] [Abstract][Full Text] [Related]
17. [The pathological basis of the argument in the treatment of melanoma of the uveal tract]. Li YP Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268 [TBL] [Abstract][Full Text] [Related]